Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
BEFREE |
Compared with dopamine D2 receptor antagonism that is exhibited by most antipsychotics, partial agonism may result in improved outcomes in major depressive disorder and in schizophrenia.
|
31406978 |
2019 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
|
25642918 |
2015 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression.
|
24555772 |
2014 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
PSYGENET |
Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression.
|
24555772 |
2014 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
PSYGENET |
Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.
|
24322206 |
2014 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
PSYGENET |
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.
|
23683269 |
2013 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.
|
23683269 |
2013 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
BEFREE |
However, we could detect no evidence of genetic association between 3 markers in DRD2 and major depressive disorder in the Chinese Han population.
|
23696934 |
2013 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
PSYGENET |
However, we could detect no evidence of genetic association between 3 markers in DRD2 and major depressive disorder in the Chinese Han population.
|
23696934 |
2013 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
The results suggest that the DRD2 gene may play a role on MDD susceptibility and the onset-time of antidepressant response.
|
22796099 |
2012 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
PSYGENET |
The results suggest that the DRD2 gene may play a role on MDD susceptibility and the onset-time of antidepressant response.
|
22796099 |
2012 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
Dopamine 2 receptor gene (DRD2) polymorphism rs6277" genes_norm="1813">C957T (rs6277) and cathechol-o-methyltransferase (COMT) polymorphism rs4680" genes_norm="1312">Val158Met (rs4680) interaction was studied in 118 patients suffering from major depressive disorder (MDD) treated with ECT and 383 healthy controls.
|
18929622 |
2008 |
Major Depressive Disorder
|
0.490 |
Biomarker
|
disease |
BEFREE |
SNPs in CCKAR, DRD1, DRD2, and HTR2C genes showed nominally significant associations with MDD.
|
15927089 |
2006 |
Major Depressive Disorder
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
These data indicate that MWA, anxiety disorders, and major depression can be components of a distinct clinical syndrome associated with allelic variations within the DRD2 gene.
|
9513185 |
1998 |